CoChat

Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease?

Burillo, Elena, Martin-Fuentes, Paula, Mateo-Gallego, Rocio, Baila-Rueda, Lucia, Cenarro, Ana, Ros, Emilio, Civeira, Fernando · 2012 · Current Vascular Pharmacology
Cited by 43

The DOI matches its Crossref record.

Abstract

Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) from marine origin have been strongly associated with cardiovascular protection, even at low doses ( < 1g/d). Despite the research performed in this promising area, basic aspects, such as the ideal doses and the mechanisms by which ω-3 PUFAs act, are not precisely defined. The best known biological property of ω-3 PUFAs is their hypotriglyceridemic effect, but other cardioprotective actions, such as reduction of arrhythmia susceptibility, antithrombotic, antiinflammatory and antioxidant effects, improvement of endothelial function, and delayed atherosclerosis development have received an increased interest in recent years. Some of these actions are also ascribable to high-density lipoproteins (HDL). Abundant epidemiological evidence links increasing HDL-cholesterol concentrations to cardiovascular protection. Recently, the protein cargo (proteome) of HDL particles has been attributed a key role in their functionality. In this review, we summarize the main effects of ω-3 PUFAs on HDL-cholesterol, HDL subfractions, and its main proteins, apolipoproteins (apo) AI and AII. The shared cardioprotective actions of ω-3 PUFAs and HDL are reviewed as well.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/157016112800812845

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 43

Metadata

Authors
Burillo, E., Martin-Fuentes, P., Mateo-Gallego, R., Baila-Rueda, L., Cenarro, A., Ros, E., & Civeira, F.
Venue
Current Vascular Pharmacology
Published
2012-05-01
Volume
10
Issue
4
Pages
432-441
ISSN
1570-1611 (ISSN-L)
OpenAlex
W2139468586
Cited by
43
References
0
FWCI
4.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease? https://app.cochat.ai/papers/10.2174/157016112800812845
The paper
Burillo, E., Martin-Fuentes, P., Mateo-Gallego, R., Baila-Rueda, L., Cenarro, A., Ros, E., & Civeira, F. (2012). Omega-3 Fatty Acids and HDL. How Do They Work in the Prevention of Cardiovascular Disease? Current Vascular Pharmacology. https://doi.org/10.2174/157016112800812845

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.